Truist Financial Corp Has $114.20 Million Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Truist Financial Corp has reduced its stake in HCA Healthcare by 3.1%, holding 298,084 shares worth approximately $114.20 million as of the latest SEC filing.
• A number of analysts have provided recent updates on HCA Healthcare, with notable changes including a price target increase by Robert W. Baird from $380.00 to $423.00 and upgrades by Wall Street Zen from "hold" to "buy."
• HCA Healthcare recently announced a quarterly dividend of $0.72 per share, translating to an annualized rate of $2.88, with a current payout ratio of 12.11%.

Truist Financial Corp reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 298,084 shares of the company's stock after selling 9,625 shares during the quarter. Truist Financial Corp owned 0.12% of HCA Healthcare worth $114,196,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. ORG Partners LLC raised its holdings in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company's stock valued at $55,000 after acquiring an additional 31 shares in the last quarter. Avantax Advisory Services Inc. raised its stake in HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after purchasing an additional 32 shares in the last quarter. Glenview Trust co increased its holdings in HCA Healthcare by 2.3% in the 1st quarter. Glenview Trust co now owns 1,451 shares of the company's stock valued at $501,000 after buying an additional 32 shares during the period. Horizon Investments LLC lifted its holdings in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock worth $1,097,000 after acquiring an additional 33 shares during the period. Finally, Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock valued at $241,000 after purchasing an additional 33 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently commented on HCA. Robert W. Baird boosted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Truist Financial increased their target price on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Morgan Stanley lowered their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $407.75.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Trading Down 0.1%

NYSE HCA opened at $425.85 on Thursday. The business's 50-day moving average price is $393.90 and its two-hundred day moving average price is $371.02. The firm has a market capitalization of $99.64 billion, a PE ratio of 17.90, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $429.43.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the prior year, the business posted $5.50 earnings per share. The firm's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.